Search results
Results from the WOW.Com Content Network
CSL Plasma is a subsidiary of its sister company CSL Behring, itself a subsidiary of CSL Limited, a biotechnology company based in Melbourne, Australia. [2] [ P 2] It is headquartered in Boca Raton, Florida, [1] and operates a total of 320 collection centers in the United States, [P 3] and a further 19 more in other nations including China, Hungary, and Germany as of 2023.
Bio Products Laboratory Limited [1] (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree, Hertfordshire, England. It is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
The Philippines' Bureau of Agriculture and Fisheries Product Standards (Filipino: Kawanihan ng mga Pamantayan sa Produktong Pansaka at Pampangisdaan, abbreviated as BAFS), is an agency of the Philippine government under the Department of Agriculture responsible for setting and implementing standards for fresh primary and secondary processed agricultural and fishery products.
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. [2] The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
Commissioning on the first phase was started in late 2014. By late 2015, Air Products halted construction on the second phase until it fixed the issues. On April 4, 2016, Air Products announced it was leaving the waste-to-energy business, and was taking a write-down of $0.9-$1.0B. [21] [22]
Plasma, often called the fourth state of matter, is an ionized gas containing positive ions and negative ions or electrons, but is approximately charge neutral on the whole. The plasma sources used for plasma medicine are generally low temperature plasmas, and they generate ions, chemically reactive atoms and molecules, and UV-photons.
In 2015, the company acquired a 45% stake in Alkahest as part of planned co-development of "plasma-based products for the treatment of cognitive decline in aging and disorders of the CNS, including Alzheimer's." [13] In 2020 Grifols acquired the remaining stock of Alkahest “bringing its ownership of Alkahest to 100%”. [14]
This includes whole blood; blood components; and plasma derivatives. Blood components include: red blood cell concentrates or suspensions; platelets produced from whole blood or via apheresis; Granulocyte, plasma; and cryoprecipitate. Some products for topical use, such as serum eye drops, have also been recently classified as blood components. [2]